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Abstract
Background: The simultaneous occurrence of Klinefelter Syndrome (KS) and Congenital Adrenal Hyperplasia (CAH)
is an exceptional event: there are just three case reports (two children and a 51 years old man) describing males
affected by both KS and 21OHD (21-hydroxylase deficiency) CAH, the first causing androgen deficiency, the latter
leading to androgen excess.
Case report: We report the 4th case of association of KS and CAH in a young man with CAH with good androgen
control and with normal secondary sex characteristics, whose Klinefelter syndrome was diagnosed because of
reduced testicular volume. He was the first reported case of association of KS and CAH who started androgen
replacement therapy in the pubertal age and whose pubertal development was described and followed up step by
step.
Conclusion: In a boy with CAH and small testicular volume, it’s important to consider that hypogonadism may be
masked by the adrenal androgens excess and a karyotype should be performed once testicular adrenal rests have
been ruled out.
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Background
In males with congenital adrenal hyperplasia (CAH), the
fertility rate is reduced compared with the healthy popu-
lation and the most frequent cause is testicular adrenal
rest tumor. However high levels of adrenal androgens
may hide hypogonadism.
We report a case of a boy with CAH caused by a 21-
hydroxylase deficiency (21OHD) and small testicular
volumes in which a chromosomal analysis revealed the
association of Klinefelter syndrome (47, XXY).
Case presentation
A CAH was suspected when he was two-years-old be-
cause of an increased growth rate with advanced bone
age, precocious pubarche, and acne. The diagnosis of
CAH was then confirmed by a pathologic ACTH stimu-
lation test and by the genetic analysis, revealing a steroid
21OHD (classic form) due to a compound heterozygos-
ity: he inherited the paternal chromosome carrying the
point mutation A/CG intron 2 (655) and the maternal
chromosome with the point mutation Ile-Asn-17 (999).
He started replacement treatment with oral hydrocorti-
sone and fludrocortisone acetate with good compliance.
Biochemical and somatic parameters were monitored
every 3 months, adjusting the therapy to gain adequate
androgen control. Some follow-up controls revealed
adrenal androgens excess.
Child’s development proceeded regularly, but he didn’t
start gonadal puberty. When he was 16 years-old, his
testicular volume was still of 3–4 ml, assessed both
using orchidometer and scrotal ultrasound. Testes ultra-
sound showed no signs of adrenal rest tumor.
He had wholly developed pubic hair and a pubertal
penis length. He also had a family history of delayed
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puberty and his bone age was delayed by 3 years. Blood
examination revealed low basal testosterone (1.82 ng/
mL), normal basal FSH (10.1 mUI/mL) and basal LH (7
mUI/mL).
LH peak after GnRH stimulation test was 34.9 mUI/
ml and FSH peak 16.2 mUI/ml.
A short hCG stimulation test was performed to assess
the testes ability to produce testosterone: it showed a
good gonadal response, with an increase in serum tes-
tosterone after hCG stimulation from a basal value of 2.
45 ng/mL to 5.53 ng/ml.
Serum antimüllerian hormone (17.3 ng/mL) and
serum inhibin B (44 ng/dL) were normal [1].
His brain magnetic resonance imaging was normal.
When he was 18, he reported a regular sexual activity
without erectile dysfunction. His physical appearance
was unremarkable, he reached his target height, and his
weight and body mass index were normal, but testicular
volume was still 4 ml. A new testes ultrasound showed
small testis with no signs of adrenal rest tumor.
Gonadotropin levels were slightly increased (FSH 12.
92 mUI/ml and LH 10.38 mUI/ml). Semen analysis
showed no sperm, even after centrifugation of the speci-
men; there were just a few round spermatids.
Then Klinefelter Syndrome was suspected, and a karyo-
type was carried out: it confirmed a 47,XXY chromosomal
arrangement on 50 metaphases, so Klinefelter Syndrome
(KS) was diagnosed. Single Nucleotide Polymorphisms-
array was normal.
Discussion
CAH affected men have problems with maintaining fer-
tility because of two major mechanisms: the first one is
gonadotropin suppression from adrenal-derived andro-
gens, which causes testicular atrophy and impairs
spermatogenesis; the second one is the development of
testicular adrenal rest tumors (TARTs), which leads to
gradual destruction of the gonad. [2, 3].
KS affects 1 in 667 live male births and is the most
common sex chromosome disorder. It is the clinical re-
sult of an additional X chromosome in males (47,XXY),
although other chromosome abnormalities (such as
46,XY/47,XXY mosaicism; 48,XXXY; 49,XXXXY) ac-
count for 10–20% of cases. Virtually all men with KS
have infertility and small testes with hypergonadotropic
hypogonadism [4, 5].
The simultaneous occurrence of KS and CAH is ex-
tremely rare: there are just three case reports describing
adult men affected by both KS and 21OHD CAH, the
first causing androgen deficiency, the latter leading to
androgen excess.
The first case was reported by Yamaguchi et al. [6] in
1994, and it is about a Japanese boy who was diagnosed as
having CAH caused by 21OHD at birth, but he was
untreated until age 10. He showed sexual precocity and
marked acceleration in somatic growth till completely
stopping growing at 9 years old, but only at 10 years old
he started steroid treatment. After age 10, he was recog-
nized as having bilateral small and firm testes: a chromo-
somal examination and a testicular biopsy revealed a
47,XXY karyotype, so the diagnosis of KS associated with
CAH was made.
Parker et al. [7] (2006) reported the case of a premature
boy with positive newborn screening for CAH, so he im-
mediately started therapy with hydrocortisone, fludrocor-
tisone, and sodium chloride supplementation. He had
mild intrauterine growth retardation and a difficult neo-
natal course; genetic test confirmed 21OHD. When he
was 8 months old his physical exam was notable for
growth retardation, poor weight gain, microcephaly, and
mild developmental delay; therefore many investigations
were ruled out, also peripheral blood cell karyotype that
revealed a mosaic 48,XXY +mar/47,XXY, indicating KS.
Cytogenetic and molecular study showed the presence of
a marker chromosome, uniparental isodisomy of chromo-
some 6, and two identical, maternally derived X chromo-
somes because of multiple episodes of nondisjunction.
The third case of association of KS and 21OHD CAH
was reported by Balestrieri [8] in 2008: they described a
51-year-old man came to their attention because of masto-
dynia; he had bilateral gynecomastia with normal
virilization and muscular masses, but both testes were
small (4 mL) with a firm consistency. He was 174.5 cm tall,
according to his genetic target height. He reported a usual
pubertal onset and development, but he was infertile be-
cause of azoospermia documented at the age of 31 years.
His blood tests showed hypergonadotropic hypogonadism
and an altered adrenal function (elevated serum ACTH
and 17-OH progesterone in the presence of normal urinary
cortisol levels). No abnormalities of sexual behavior, in par-
ticular of libido, erectile function, and sexual intercourse,
were ever reported in his life. KS and CAH resulting from
21OHD were suspected and then confirmed; in particular,
karyotype analysis showed a 47,XXY polysomy, the biopsy
of the testis revealed atrophied seminiferous tubules with
Leydig cell hyperplasia, the ACTH stimulation test and
CYP21 gene analysis were consistent with the diagnosis of
nonclassical 21OHD. He was treated initially with an only
corticosteroid replacement therapy, but a worsening of
hypogonadism and the onset of sexual symptoms (progres-
sive reduction of sexual desire and erectile function) oc-
curred, then he also started androgen replacement therapy.
He also underwent mammary plastic surgery.
The interest in describing our case report lies in the
age and the clinical history of our patient: he is the first
one whose the simultaneous occurrence of KS and CAH
was diagnosed in the young adult age and whose puber-
tal development was followed step by step.
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Unlike the Yamamughi case but similar to Parker case,
our patient started steroid replacement therapy since he
was a child (Parker’s patient from the newborn period,
our patient from 2 years of age) with good adrenal axis
control (unlike the Yamamughi case).
In the first two cases of association between KS and
CAH [6, 7] previously reported in the literature, early
diagnosis did not allow investigation of the adult pheno-
type and the pathophysiological correlates, while the
third one [8] reported a 51 years old man characterized
by very mild clinical features of the two syndromes that
became evident only in adulthood and he had never
been treated with hormonal replacement therapy before.
KS was expressed in our case with small testes and
azoospermia, without clear hypergonadotropic hypo-
gonadism and with an average virilized phenotype, a
height in the genetic target and no psychosocial morbid-
ity (he is now going to graduate in a scientific faculty at
the university). He was similar to the Balestrieri’s patient,
but he had a classic CAH, no gynecomastia, he was
younger and he had always been treated with steroid
replacement therapy.
Balestrieri et al. hypothesized that the high levels of
adrenal androgens because of CAH were responsible for
his patient’s normal pubertal onset, sexual behavior, nor-
mal virilization and muscular tropism in adulthood, thus
counterbalancing the partial deficiency of androgens of
testicular origin because of KS.
Their hypothesis that adrenal androgen excess masked
the KS-related hypogonadism is supported by the quick
and progressive deterioration of sexual health with the
lowering of serum testosterone levels when corticoster-
oid therapy was started in their patient.
These considerations could not be applied entirely to
our case because he had relatively reasonable control of
the androgen excess since he was 2 years old (just some
follow-up controls revealed adrenal androgen excess).
Perhaps, clinical expression of the association of KS
and 21OHD CAH may be different in different ages, and
there may be an unpredictable clinical response to re-
placement therapy in the various subjects. Some recent
studies [9] [10] showed an association among the length
of androgen receptor CAGn repeats, different pheno-
types, and social characteristics in men with KS, but the
role of this receptor is still unclear.
Our patient KS phenotype could be attenuated by ad-
renal androgen excess despite apparent good control at
the 3 months follow up blood tests.
Conclusion
This is the 4th case report of the simultaneous occur-
rence of KS and CAH.
In a boy with CAH and small testicular volume, it’s
important to consider that hypogonadism may be
masked by the adrenal androgens excess and a karyotype
should be performed once testicular adrenal rests have
been ruled out.
When considering the frequency of both 21-OH defi-
ciency and Klinefelter syndrome, the association between
these two diseases should be expected to be higher than
documented (only 3 cases reported since now).
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